Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 11—November 2020
Letter

Nocardia ignorata Infection in Heart Transplant Patient

On This Page
Article Metrics

Cite This Article

To the Editor: We read with interest the recent description of pulmonary Nocardia ignorata infection (1). We report a similar infection in an orthotopic heart transplant recipient, which likely began as a pulmonary infection with dissemination to soft tissue, without known exposure. Risk factors included tacrolimus, steroids, older age, and posttransplant intensive care unit admission (2).

The patient was a 66-year-old African American man with a history of ischemic cardiomyopathy. After implantation of a left ventricular assist device, infectious complications included Enterococcus faecalis device infection and extended spectrum β-lactamase–producing (ESBL) Klebsiella urosepsis. The course after left ventricular assist device explantation and orthotopic heart transplant was complicated by tamponade requiring a pericardial window and an ESBL Klebsiella urinary tract infection treated with meropenem. Because of leukopenia, Pneumocystis prophylaxis was changed from trimethoprim/sulfamethoxazole to atovaquone 2 weeks posttransplant. ESBL Klebsiella bacteremia recurred 6 weeks later, again treated with meropenem.

The patient returned 6 months posttransplant with 10 days of cough and dyspnea. Chest computed tomography demonstrated bilateral nodules with cavitation, bronchiectasis, and spiculation. We initially treated the patient with meropenem and doxycycline. Results from severe acute respiratory syndrome coronavirus 2 swab test, respiratory pathogen panel, fungal studies, and sputum culture were nondiagnostic. We obtained no additional pulmonary samples.

Due to severe left calf pain, venous duplex was performed, revealing a nonvascular mass. The patient reported no trauma, soil contact, or recent travel. The abscess was aspirated, demonstrating branching gram-positive beaded rods. The isolate was identified by a reference laboratory (Mycobacteria and Nocardia Laboratory, University of Texas Health Center at Tyler, Tyler, TX, USA) by partial 16S rRNA sequencing as a 99.51% match with Nocardia ignorata, with susceptibilities identical to the isolate in Rahdar et al. (1). Brain magnetic resonance imaging results were unremarkable. The patient’s respiratory status and leg pain quickly improved and he was discharged on long-term trimethoprim/sulfamethoxazole and doxycycline. Because of renal insufficiency, trimethoprim/sulfamethoxazole was switched to moxifloxacin after 2 weeks. Chest radiograph results were improving 3 months later.

Top

Victoria A. Muggia and Yoram A. PuiusComments to Author 

Author affiliation: Albert Einstein College of Medicine, Bronx, NY, USA; Montefiore Medical Center, Bronx

Top

References

  1. Rahdar  HA, Gharabaghi  MA, Bahador  A, Shahraki-Zahedani  S, Karami-Zarandi  M, Mahmoudi  S, et al. Pulmonary Nocardia ignorata infection in gardener, Iran, 2017. Emerg Infect Dis. 2020;26:6101. DOIPubMed
  2. Coussement  J, Lebeaux  D, van Delden  C, Guillot  H, Freund  R, Marbus  S, et al.; European Study Group for Nocardia in Solid Organ Transplantation. Nocardia infection in solid organ transplant recipients: a multicenter European case-control study. Clin Infect Dis. 2016;63:33845. DOIPubMed

Top

Cite This Article

DOI: 10.3201/eid2611.202756

Original Publication Date: October 13, 2020

Related Links

Top

Table of Contents – Volume 26, Number 11—November 2020

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Yoram A. Puius, Division of Infectious Diseases, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA; e-mail: ypuius@montefiore.org

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: August 28, 2020
Page updated: October 19, 2020 2:26 PM EDT
Page reviewed: October 19, 2020 2:26 PM EDT
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external